» Articles » PMID: 33114502

Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD)

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Oct 29
PMID 33114502
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive lung disease (COPD) is responsible for substantial rates of mortality and economic burden, and is one of the most important public-health concerns. As the disease characteristics include irreversible airway obstruction and progressive lung function decline, there has been a great deal of interest in detection at the early stages of COPD during the "at risk" or undiagnosed preclinical stage to prevent the disease from progressing to the overt stage. Previous studies have used various definitions of early COPD, and the term mild COPD has also often been used. There has been a great deal of recent effort to establish a definition of early COPD, but comprehensive evaluation is still required, including identification of risk factors, various physiological and radiological tests, and clinical manifestations for diagnosis of early COPD, considering the heterogeneity of the disease. The treatment of early COPD should be considered from the perspective of prevention of disease progression and management of clinical deterioration. There has been a lack of studies on this topic as the definition of early COPD has been proposed only recently, and therefore further clinical studies are needed.

Citing Articles

A Comparative Observational Study of the Diagnostic Utility of Impulse Oscillometry Versus Spirometry in Obstructive Airway Diseases.

Sarkar S, Jadhav U, Ghewade B, Sarkar S Cureus. 2024; 16(10):e70589.

PMID: 39483551 PMC: 11527509. DOI: 10.7759/cureus.70589.


Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany.

Vogelmeier C, Beeh K, Kardos P, Paulsson T, Rohde G, Watz H Ther Adv Respir Dis. 2024; 18():17534666241287621.

PMID: 39436955 PMC: 11526303. DOI: 10.1177/17534666241287621.


Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).

Lai Y, Tsai Y, Hsieh M, Chen N, Cheng S, Tao C Respir Res. 2024; 25(1):377.

PMID: 39420386 PMC: 11487693. DOI: 10.1186/s12931-024-02971-3.


Using machine learning for early detection of chronic obstructive pulmonary disease: a narrative review.

Shen X, Liu H Respir Res. 2024; 25(1):336.

PMID: 39252086 PMC: 11385799. DOI: 10.1186/s12931-024-02960-6.


Twenty years of changes in the definition of early chronic obstructive pulmonary disease.

Chen D, Curtis J, Chen Y Chin Med J Pulm Crit Care Med. 2024; 1(2):84-93.

PMID: 39170827 PMC: 11332824. DOI: 10.1016/j.pccm.2023.03.004.


References
1.
Bhatt S, Soler X, Wang X, Murray S, Anzueto A, Beaty T . Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2016; 194(2):178-84. PMC: 5003216. DOI: 10.1164/rccm.201511-2219OC. View

2.
Woodruff P, Barr R, Bleecker E, Christenson S, Couper D, Curtis J . Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med. 2016; 374(19):1811-21. PMC: 4968204. DOI: 10.1056/NEJMoa1505971. View

3.
Kania A, Krenke R, Kuziemski K, Czajkowska-Malinowska M, Celejewska-Wojcik N, Kuznar-Kaminska B . Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study. Int J Chron Obstruct Pulmon Dis. 2018; 13:1613-1621. PMC: 5963485. DOI: 10.2147/COPD.S154716. View

4.
Xia Y, Guan Y, Fan L, Liu S, Yu H, Zhao L . Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography. COPD. 2014; 11(5):510-20. DOI: 10.3109/15412555.2014.948990. View

5.
Terzikhan N, Verhamme K, Hofman A, Stricker B, Brusselle G, Lahousse L . Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016; 31(8):785-92. PMC: 5005388. DOI: 10.1007/s10654-016-0132-z. View